To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SLC25A29TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
501 supporting clones for gene SLC25A29 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CV355355 bocio_tumor SLC25A29.a 1 to 356 38 to 399   tiling clone,   367/399
(91 %)
6 diff
(98.5 %id)
BF359360 lung_tumor SLC25A29.a 294 to 592 1 to 300   tiling clone,   300/338
(88 %)
9 diff
(97.4 %id)
DA188365 amygdala SLC25A29.a 387 to 664 2 to 279   capped   278/278
(100 %)
1 diff
(99.7 %id)
AK094455 cerebellum SLC25A29.a 561 to 1574 547 to 1561   tiling clone, available from FLJ,   1015/1561
(65 %)
6 diff
(99.7 %id)
CN341068 embryonic stem cells, cell lines H1, H7, andH9 SLC25A29.a 1371 to 1952 1 to 587   tiling clone,   587/587
(100 %)
15 diff
(97.5 %id)
CN341060 embryonic stem cells, cell lines H1, H7, andH9 SLC25A29.a 1646 to 2103 1 to 458       458/458
(100 %)
4 diff
(99.2 %id)
CN341056 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells SLC25A29.a 1657 to 2364 1 to 707   tiling clone,   707/707
(100 %)
1 diff
(99.9 %id)
BX418645 brain, fetal brain SLC25A29.a 1901 to 2752 1 to 851       851/851
(100 %)
1 diff
(99.9 %id)
BX449864 brain, fetal brain SLC25A29.a 1901 to 2863 1 to 953       953/953
(100 %)
15 diff
(98.5 %id)
AL832299 lymph node SLC25A29.a 1926 to 6812 1 to 4887 exact tiling clone, available from DKFZ, AAA   4887/4887
(100 %)
1 diff
(100.0 %id)
DA334712 hippocampus SLC25A29.a 2138 to 2727 2 to 592   capped   591/594
(99 %)
2 diff
(99.7 %id)
DA186270 amygdala SLC25A29.a 2288 to 2855 2 to 570   capped   569/569
(100 %)
3 diff
(99.5 %id)
CN341061 embryonic stem cells, cell lines H1, H7, andH9 SLC25A29.a 2312 to 2813 1 to 501       501/501
(100 %)
5 diff
(99.1 %id)
DA327663 hippocampus SLC25A29.a 2458 to 3023 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
BX408205 brain, fetal brain SLC25A29.a 2638 to 3180 1 to 543       543/543
(100 %)
24 diff
(95.6 %id)
DA230318 brain SLC25A29.a 2849 to 3422 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA212257 brain SLC25A29.a 2857 to 3388 2 to 533   capped   532/532
(100 %)
0 diff
(100 %id)
DA221799 brain SLC25A29.a 2961 to 3521 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
EB387964 eye, optic nerve SLC25A29.a 2994 to 3571 1 to 578       578/578
(100 %)
1 diff
(99.9 %id)
DB065566 testis SLC25A29.a 3101 to 3607 2 to 508   capped   507/507
(100 %)
0 diff
(100 %id)
DA194195 amygdala SLC25A29.a 3148 to 3731 2 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
DA402565 thalamus SLC25A29.a 3315 to 3893 2 to 581   capped   580/580
(100 %)
1 diff
(99.9 %id)
DA248531 brain SLC25A29.a 3327 to 3912 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
DA804928 brain SLC25A29.a 3394 to 3759 2 to 367   capped   366/366
(100 %)
3 diff
(99.2 %id)
DA807050 brain SLC25A29.a 3395 to 3952 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA247926 brain SLC25A29.a 3397 to 3756 2 to 370   capped   369/369
(100 %)
11 diff
(97.1 %id)
DA123481 cerebellum SLC25A29.a 3398 to 3941 2 to 546   capped   545/545
(100 %)
1 diff
(99.9 %id)
DB149399 thymus SLC25A29.a 3588 to 4068 2 to 482   capped   481/481
(100 %)
0 diff
(100 %id)
DA808946 brain SLC25A29.a 3593 to 4163 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA799408 brain SLC25A29.a 3692 to 4240 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA303109 hippocampus SLC25A29.a 3810 to 4276 2 to 468   capped   467/467
(100 %)
1 diff
(99.8 %id)
DA796215 brain SLC25A29.a 3810 to 4381 2 to 574   capped   573/576
(99 %)
2 diff
(99.7 %id)
CN341066 embryonic stem cells, cell lines H1, H7, andH9 SLC25A29.a 3891 to 4645 1 to 755       755/755
(100 %)
2 diff
(99.8 %id)
CN341054 embryonic stem cells, cell lines H1, H7, andH9 SLC25A29.a 3899 to 4316 1 to 418       418/418
(100 %)
0 diff
(100 %id)
BE163246 head_neck SLC25A29.a 3953 to 4301 349 to 1     Submitted on the opposite strand 349/349
(100 %)
5 diff
(98.6 %id)
AK095532 brain SLC25A29.a 3981 to 6812 1 to 2832 exact available from FLJ,   2832/2832
(100 %)
1 diff
(100.0 %id)
DA483474 brain SLC25A29.a 3982 to 4516 2 to 536   capped   535/535
(100 %)
5 diff
(99.1 %id)
DA794490 brain SLC25A29.a 3987 to 4538 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
DB142774 thymus SLC25A29.a 3989 to 4516 2 to 529   capped   528/528
(100 %)
0 diff
(100 %id)
DB154267 thymus SLC25A29.a 3990 to 4587 2 to 599   capped   598/598
(100 %)
2 diff
(99.7 %id)
DB159229 thymus SLC25A29.a 4004 to 4579 2 to 577   capped   576/576
(100 %)
2 diff
(99.7 %id)
CR600978 Placenta Cot 25-normalized SLC25A29.a 4007 to 6801 1 to 2795 exact     2795/2795
(100 %)
0 diff
(100 %id)
BX382440 Placenta Cot 25-normalized SLC25A29.a 4007 to 5044 1 to 1022       1022/1022
(100 %)
28 diff
(97.3 %id)
BX361131 Placenta Cot 25-normalized SLC25A29.a 4007 to 4757 1 to 767       767/811
(94 %)
44 diff
(94.6 %id)
BX367671 Placenta Cot 25-normalized SLC25A29.a 4007 to 4985 1 to 975       975/980
(99 %)
18 diff
(98.2 %id)
DA443040 tongue, tumor tissue SLC25A29.a 4072 to 4630 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
DA735355   SLC25A29.a 4077 to 4842 2 to 763   capped   762/767
(99 %)
16 diff
(98.0 %id)
DA497166 brain SLC25A29.a 4083 to 4620 2 to 539   capped   538/538
(100 %)
1 diff
(99.9 %id)
BG999449 head_normal SLC25A29.a 4185 to 4656 24 to 495       472/495
(95 %)
6 diff
(98.8 %id)
DB128990 thymus SLC25A29.a 4228 to 4787 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
DA936747 Spleen SLC25A29.a 4233 to 4716 2 to 485   capped   484/486
(99 %)
3 diff
(99.4 %id)
AW407585 lymph SLC25A29.a 4236 to 4550 1 to 315       315/315
(100 %)
5 diff
(98.5 %id)
DB272690 uterus SLC25A29.a 4240 to 4778 2 to 540   capped   539/539
(100 %)
2 diff
(99.7 %id)
TI_154145983   SLC25A29.a 4243 to 4908 82 to 747       666/813
(81 %)
41 diff
(95.0 %id)
TI_154147329   SLC25A29.a 4243 to 4656 81 to 494       414/414
(100 %)
4 diff
(99.1 %id)
BQ890665 dorsal root ganglia SLC25A29.a 4329 to 5153 27 to 863       837/954
(87 %)
32 diff
(96.7 %id)
CK430841 eye, lacrimal gland SLC25A29.a 4329 to 4965 1 to 637       637/637
(100 %)
1 diff
(99.9 %id)
DA167248 amygdala SLC25A29.a 4370 to 4951 2 to 583   capped   582/582
(100 %)
2 diff
(99.7 %id)
BF823100 kidney_tumor SLC25A29.a 4413 to 4963 1 to 553       553/555
(99 %)
41 diff
(92.7 %id)
CN341069 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 SLC25A29.a 4416 to 4657 1 to 243       243/243
(100 %)
2 diff
(99.2 %id)
BF835876 head_neck SLC25A29.a 4444 to 4788 27 to 372       346/372
(93 %)
6 diff
(98.4 %id)
BF835874 head_neck SLC25A29.a 4450 to 4823 23 to 397       375/397
(94 %)
8 diff
(98.0 %id)
BF835877 head_neck SLC25A29.a 4454 to 4790 13 to 352       340/352
(96 %)
7 diff
(98.1 %id)
BM719210 eye, fetal eye SLC25A29.a 4460 to 5185 1 to 726       726/726
(100 %)
2 diff
(99.8 %id)
BX326366 Placenta Cot 25-normalized SLC25A29.a 4479 to 5291 1 to 813       813/881
(92 %)
53 diff
(94.0 %id)
BM151670 leukopheresis SLC25A29.a 4488 to 4815 1 to 328       328/329
(99 %)
7 diff
(97.9 %id)
DA936312 Spleen SLC25A29.a 4521 to 5116 2 to 597   capped   596/596
(100 %)
1 diff
(99.9 %id)
DB264043 uterus SLC25A29.a 4530 to 5049 2 to 520   capped   519/519
(100 %)
3 diff
(99.5 %id)
AA284872 ovarian tumor, ovary SLC25A29.a 4552 to 4999 1 to 447       447/450
(99 %)
4 diff
(99.2 %id)
BX367932 Placenta Cot 25-normalized SLC25A29.a 4584 to 5090 1 to 507       507/724
(70 %)
11 diff
(98.5 %id)
BP209577 cerebellum SLC25A29.a 4612 to 5191 1 to 580       580/582
(99 %)
6 diff
(99.0 %id)
BI915896 brain SLC25A29.a 4652 to 5273 1 to 625       625/625
(100 %)
9 diff
(98.6 %id)
TI_57244420   SLC25A29.a 4652 to 5323 33 to 710       678/897
(75 %)
18 diff
(98.0 %id)
DR423018 eye, Pterygium SLC25A29.a 4673 to 5442 1 to 770       770/770
(100 %)
3 diff
(99.7 %id)
DA192236 amygdala SLC25A29.a 4681 to 5266 2 to 588   capped   587/587
(100 %)
3 diff
(99.5 %id)
DA385572 thalamus SLC25A29.a 4686 to 5241 2 to 558   capped   557/557
(100 %)
4 diff
(99.3 %id)
DA283924 corpus callosum SLC25A29.a 4690 to 5265 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DB126992 thymus SLC25A29.a 4690 to 5264 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
BX326002 Placenta Cot 25-normalized SLC25A29.a 4696 to 5549 1 to 851       851/855
(99 %)
26 diff
(97.0 %id)
BM174950 hippocampus SLC25A29.a 4701 to 5115 7 to 421       415/421
(98 %)
6 diff
(98.6 %id)
DA073269 cerebellum SLC25A29.a 4746 to 5295 2 to 551   capped   550/550
(100 %)
2 diff
(99.7 %id)
CR618322 fetal brain SLC25A29.a 4898 to 6780 1 to 1883       1883/1883
(100 %)
0 diff
(100 %id)
TI_1752769744   SLC25A29.a 5484 to 6654 1224 to 68       1157/1252
(92 %)
0 diff
(100 %id)
CX782934 human embryonic stem cells SLC25A29.a 5574 to 6242 1 to 670       670/670
(100 %)
6 diff
(99.2 %id)
CR598575 fetal brain SLC25A29.a 5643 to 6814 1 to 1172       1172/1172
(100 %)
0 diff
(100 %id)
BX376192 Neuroblastoma Cot 25-normalized SLC25A29.a 5686 to 6789 1096 to 7       1090/1120
(97 %)
0 diff
(100 %id)
BX382439 Placenta Cot 25-normalized SLC25A29.a 5699 to 6801 1095 to 1       1095/1131
(96 %)
19 diff
(98.4 %id)
BM702868 eye, Retina Foveal and Macular SLC25A29.a 5720 to 6309 1 to 590       590/590
(100 %)
0 diff
(100 %id)
Z44676 brain, total brain SLC25A29.a 5743 to 6044 1 to 302       302/302
(100 %)
0 diff
(100 %id)
H15376 whole brain SLC25A29.a 5744 to 6214 1 to 489       489/489
(100 %)
32 diff
(93.5 %id)
BX388359 Neuroblastoma Cot 25-normalized SLC25A29.a 5769 to 6802 1021 to 1       1021/1021
(100 %)
22 diff
(97.9 %id)
BX449863 brain, fetal brain SLC25A29.a 5777 to 6801 1020 to 1       1020/1032
(98 %)
14 diff
(98.7 %id)
BX407822 brain, fetal brain SLC25A29.a 5793 to 6799 999 to 1       999/999
(100 %)
15 diff
(98.5 %id)
BX449945 brain, fetal brain SLC25A29.a 5808 to 6783 973 to 1       973/973
(100 %)
26 diff
(97.4 %id)
BX449923 brain, fetal brain SLC25A29.a 5817 to 6768 945 to 12       934/945
(98 %)
0 diff
(100 %id)
BX332814 Neuroblastoma Cot 25-normalized SLC25A29.a 5826 to 6723 873 to 1       873/878
(99 %)
52 diff
(94.1 %id)
BX432582 brain, fetal brain SLC25A29.a 5830 to 6769 936 to 1       936/936
(100 %)
6 diff
(99.4 %id)
BX353035 Neuroblastoma Cot 10-normalized SLC25A29.a 5871 to 6793 925 to 1       925/936
(98 %)
75 diff
(92.0 %id)
BX374005   SLC25A29.a 5889 to 6809 924 to 1       924/927
(99 %)
50 diff
(94.7 %id)
TI_151756955   SLC25A29.a 5890 to 6812 997 to 87   AAA   911/955
(95 %)
23 diff
(97.6 %id)
CV810647 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass SLC25A29.a 5897 to 6632 18 to 755       738/757
(97 %)
15 diff
(98.1 %id)
TI_149313511   SLC25A29.a 5908 to 6812 983 to 93   AAA   891/1004
(88 %)
26 diff
(97.5 %id)
TI_149301245   SLC25A29.a 5920 to 6812 909 to 29   AAA   881/962
(91 %)
17 diff
(98.3 %id)
TI_149314941   SLC25A29.a 5958 to 6812 928 to 88   AAA   841/997
(84 %)
27 diff
(97.3 %id)
TI_149286711   SLC25A29.a 5961 to 6812 935 to 87   AAA   849/1184
(71 %)
35 diff
(97.1 %id)
TI_149300752   SLC25A29.a 5967 to 6812 910 to 76   AAA   835/976
(85 %)
15 diff
(98.5 %id)
BF829474 head_normal SLC25A29.a 6003 to 6586 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
BX392580 Placenta Cot 25-normalized SLC25A29.a 6013 to 6807 800 to 1       800/913
(87 %)
20 diff
(97.9 %id)
TI_149313233   SLC25A29.a 6015 to 6812 876 to 88   AAA   789/954
(82 %)
10 diff
(99.0 %id)
TI_149277891   SLC25A29.a 6023 to 6812 875 to 95   AAA   781/1068
(73 %)
20 diff
(98.2 %id)
TI_149286031   SLC25A29.a 6039 to 6812 846 to 78   AAA   769/811
(94 %)
12 diff
(98.6 %id)
BX455463 brain, fetal brain SLC25A29.a 6041 to 6808 775 to 1       775/799
(96 %)
30 diff
(96.3 %id)
TI_149298903   SLC25A29.a 6045 to 6812 848 to 87   AAA   762/938
(81 %)
9 diff
(99.1 %id)
BX435060.
matches multiple genes
brain, fetal brain SLC25A29.a 6062 to 6810 753 to 1     also hits gene PTPN18 753/759
(99 %)
35 diff
(95.4 %id)
BX352374   SLC25A29.a 6065 to 6815 754 to 1       754/782
(96 %)
26 diff
(96.7 %id)
CB850912 lung, Primary Lung Cystic Fibrosis EpithelialCells SLC25A29.a 6066 to 6706 640 to 1       640/640
(100 %)
3 diff
(99.6 %id)
BM976758 lung, Primary Lung Cystic Fibrosis EpithelialCells SLC25A29.a 6071 to 6812 758 to 19   AAA   740/740
(100 %)
4 diff
(99.5 %id)
BG775427 carcinoma, cell line, Prostate SLC25A29.a 6072 to 6628 738 to 179       560/741
(75 %)
0 diff
(100 %id)
TI_151719916   SLC25A29.a 6075 to 6812 817 to 78   AAA   740/1302
(56 %)
23 diff
(98.3 %id)
BX413631 brain, fetal brain SLC25A29.a 6078 to 6807 721 to 1       721/760
(94 %)
23 diff
(97.0 %id)
CF541268 lung SLC25A29.a 6078 to 6812 751 to 19   AAA   733/733
(100 %)
3 diff
(99.6 %id)
BU508774 leiomyosarcoma, uterus SLC25A29.a 6095 to 6796 1 to 705       705/758
(93 %)
5 diff
(99.4 %id)
BU684807 lung, Primary Lung Cystic Fibrosis EpithelialCells SLC25A29.a 6096 to 6812 734 to 19   AAA   716/716
(100 %)
3 diff
(99.6 %id)
BQ227143 embryonal carcinoma, cell line, testis SLC25A29.a 6100 to 6812 1 to 713   AAA   713/713
(100 %)
0 diff
(100 %id)
CB305410 lung, Primary Lung Cystic Fibrosis EpithelialCells SLC25A29.a 6100 to 6812 731 to 19   AAA   713/713
(100 %)
3 diff
(99.6 %id)
DB542590 hippocampus SLC25A29.a 6102 to 6812 1 to 708   AAA Submitted on the opposite strand 708/708
(100 %)
10 diff
(98.6 %id)
DB728156 hippocampus SLC25A29.a 6102 to 6812 1 to 710   AAA Submitted on the opposite strand 710/710
(100 %)
3 diff
(99.6 %id)
BF340986 brain, glioblastoma with EGFR amplification SLC25A29.a 6105 to 6778 1 to 673       673/673
(100 %)
1 diff
(99.9 %id)
CA423688 cell lines, Chondrosarcoma SLC25A29.a 6110 to 6812 721 to 19   AAA   703/703
(100 %)
2 diff
(99.8 %id)
BM772805 Ascites, stomach SLC25A29.a 6112 to 6693 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BX412717 brain, fetal brain SLC25A29.a 6113 to 6814 710 to 1       710/762
(93 %)
62 diff
(91.9 %id)
CA423636 cell lines, Chondrosarcoma SLC25A29.a 6123 to 6812 708 to 19   AAA   690/690
(100 %)
3 diff
(99.6 %id)
BM683159 eye, fetal eye SLC25A29.a 6124 to 6812 707 to 19   AAA   689/689
(100 %)
1 diff
(99.9 %id)
DB531417 hippocampus SLC25A29.a 6153 to 6812 1 to 660   AAA Submitted on the opposite strand 660/660
(100 %)
7 diff
(99.0 %id)
BU680888 lung SLC25A29.a 6169 to 6812 661 to 19   AAA   643/643
(100 %)
1 diff
(99.9 %id)
BU678045 lung SLC25A29.a 6172 to 6812 659 to 19   AAA   641/641
(100 %)
3 diff
(99.6 %id)
CB851686 lung, Primary Lung Cystic Fibrosis EpithelialCells SLC25A29.a 6172 to 6812 658 to 19   AAA   640/640
(100 %)
1 diff
(99.9 %id)
BQ276252 carcinoma, cell line, Prostate SLC25A29.a 6177 to 6814 687 to 45     Submitted on the opposite strand 643/1090
(58 %)
35 diff
(96.8 %id)
N44196 multiple sclerosis lesions SLC25A29.a 6178 to 6425 11 to 256   fully sequenced,   246/256
(96 %)
2 diff
(99.3 %id)
BU733916 eye, Retina Foveal and Macular SLC25A29.a 6178 to 6812 652 to 19   AAA   634/634
(100 %)
2 diff
(99.7 %id)
BQ002486 Chondrosarcoma, Left Pelvis SLC25A29.a 6180 to 6812 652 to 19   AAA   634/634
(100 %)
1 diff
(99.9 %id)
D60022   SLC25A29.a 6189 to 6529 3 to 338   fully sequenced,   336/338
(99 %)
9 diff
(97.4 %id)
C14604   SLC25A29.a 6194 to 6607 8 to 421       414/428
(96 %)
7 diff
(98.4 %id)
BM746559 stomach SLC25A29.a 6202 to 6783 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BM833078 stomach SLC25A29.a 6202 to 6811 1 to 610       610/610
(100 %)
0 diff
(100 %id)
BM833105 stomach SLC25A29.a 6202 to 6814 1 to 613       613/614
(99 %)
1 diff
(99.9 %id)
BF529198 anaplastic oligodendroglioma with 1p/19qloss, brain SLC25A29.a 6207 to 6814 1 to 610       610/640
(95 %)
6 diff
(99.1 %id)
BM701853 eye, optic nerve SLC25A29.a 6227 to 6811 1 to 586   fully sequenced,   586/586
(100 %)
1 diff
(99.9 %id)
BX346780   SLC25A29.a 6232 to 6754 525 to 1       525/808
(64 %)
54 diff
(93.4 %id)
DB304474 brain SLC25A29.a 6260 to 6812 553 to 1       553/553
(100 %)
1 diff
(99.9 %id)
DB303255 amygdala SLC25A29.a 6270 to 6812 543 to 1       543/543
(100 %)
1 diff
(99.9 %id)
AI826268 normal prostate, Prostate SLC25A29.a 6279 to 6812 551 to 18   AAA   534/534
(100 %)
1 diff
(99.9 %id)
AA533275 invasive prostate tumor, Prostate SLC25A29.a 6281 to 6812 545 to 23   AAA   523/570
(91 %)
19 diff
(96.7 %id)
BX367670 Placenta Cot 25-normalized SLC25A29.a 6291 to 6794 502 to 1       502/510
(98 %)
4 diff
(99.3 %id)
DB367595   SLC25A29.a 6301 to 6817 517 to 1       517/517
(100 %)
7 diff
(98.7 %id)
CX782856 human embryonic stem cells SLC25A29.a 6310 to 6812 535 to 33   AAA   503/503
(100 %)
6 diff
(98.9 %id)
BM972234 lung SLC25A29.a 6310 to 6812 520 to 19   AAA   502/502
(100 %)
1 diff
(99.9 %id)
BX450696 brain, fetal brain SLC25A29.a 6316 to 6814 1 to 499       499/499
(100 %)
2 diff
(99.6 %id)
BQ638424 eye, retina SLC25A29.a 6320 to 6812 1 to 493   AAA   493/493
(100 %)
0 diff
(100 %id)
H69511 nose, olfactory epithelium SLC25A29.a 6328 to 6521 1 to 205   fully sequenced,   205/205
(100 %)
0 diff
(100 %id)
TI_157609614   SLC25A29.a 6332 to 6819 594 to 103   AAA   492/623
(78 %)
27 diff
(95.7 %id)
AI748806 colon SLC25A29.a 6333 to 6812 480 to 1       480/480
(100 %)
0 diff
(100 %id)
AI890377 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus SLC25A29.a 6333 to 6813 481 to 1       481/481
(100 %)
0 diff
(100 %id)
AI992254 anaplastic oligodendroglioma, brain SLC25A29.a 6333 to 6812 480 to 1       480/480
(100 %)
0 diff
(100 %id)
AW779557 Kidney SLC25A29.a 6333 to 6814 486 to 5       482/486
(99 %)
0 diff
(100 %id)
AW151271 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors SLC25A29.a 6340 to 6812 473 to 1       473/473
(100 %)
0 diff
(100 %id)
BM669653 eye, fetal eyes SLC25A29.a 6341 to 6812 490 to 19   AAA   472/472
(100 %)
0 diff
(100 %id)
CK823863 insulinoma, Pancreas SLC25A29.a 6345 to 6812 484 to 17   AAA   468/473
(98 %)
0 diff
(100 %id)
BF478151 pooled germ cell tumors SLC25A29.a 6346 to 6813 468 to 1       468/468
(100 %)
0 diff
(100 %id)
AI356374 B-cell, chronic lymphotic leukemia SLC25A29.a 6348 to 6814 470 to 4       467/470
(99 %)
0 diff
(100 %id)
AI634503 carcinoid, lung SLC25A29.a 6348 to 6814 467 to 1       467/467
(100 %)
1 diff
(99.8 %id)
BM510630 insulinoma, Pancreas SLC25A29.a 6354 to 6812 475 to 17   AAA   459/459
(100 %)
0 diff
(100 %id)
AA777065 heart SLC25A29.a 6359 to 6814 454 to 1       454/454
(100 %)
2 diff
(99.6 %id)
AI590131 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus SLC25A29.a 6364 to 6814 457 to 7       451/457
(98 %)
0 diff
(100 %id)
BX110754 whole brain SLC25A29.a 6365 to 6805 461 to 21   AAA   441/447
(98 %)
0 diff
(100 %id)
AI889058 anaplastic oligodendroglioma, brain SLC25A29.a 6366 to 6812 459 to 13   AAA   447/447
(100 %)
2 diff
(99.6 %id)
BM709293 eye, optic nerve SLC25A29.a 6366 to 6811 1 to 446       446/446
(100 %)
0 diff
(100 %id)
TI_151745706   SLC25A29.a 6366 to 6812 533 to 87   AAA   447/923
(48 %)
0 diff
(100 %id)
AA046480 eye, retina SLC25A29.a 6376 to 6813 436 to 1       436/436
(100 %)
2 diff
(99.6 %id)
AI573008 lymph node, lymphoma, follicular mixed small and largecell SLC25A29.a 6378 to 6814 438 to 2       437/438
(99 %)
0 diff
(100 %id)
H37767 eye, retina SLC25A29.a 6380 to 6794 418 to 1       418/429
(97 %)
4 diff
(99.1 %id)
AW130925 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus SLC25A29.a 6381 to 6812 460 to 29   AAA   432/432
(100 %)
10 diff
(97.7 %id)
N27343 nose, olfactory epithelium SLC25A29.a 6382 to 6813 437 to 1       437/437
(100 %)
10 diff
(97.8 %id)
AI635838 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus SLC25A29.a 6383 to 6812 441 to 12   AAA   430/430
(100 %)
0 diff
(100 %id)
BM709291 eye, optic nerve SLC25A29.a 6384 to 6812 1 to 429   fully sequenced, AAA   429/429
(100 %)
0 diff
(100 %id)
CX751112 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass SLC25A29.a 6386 to 6809 1 to 424   AAA Submitted on the opposite strand 424/424
(100 %)
0 diff
(100 %id)
BG056316 brain, glioblastoma with probably TP53 mutation andwithout EGFR amplification SLC25A29.a 6394 to 6813 420 to 1       420/420
(100 %)
0 diff
(100 %id)
N34308 multiple sclerosis lesions SLC25A29.a 6395 to 6812 401 to 1   fully sequenced,   401/401
(100 %)
8 diff
(98.1 %id)
AI208239   SLC25A29.a 6395 to 6812 432 to 15   AAA   418/418
(100 %)
0 diff
(100 %id)
AI275835 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus SLC25A29.a 6395 to 6813 419 to 1       419/419
(100 %)
0 diff
(100 %id)
AW000790 colon, colonic mucosa from 3 patients with Crohn'sdisease SLC25A29.a 6395 to 6814 420 to 1       420/420
(100 %)
0 diff
(100 %id)
BG059610 brain, glioblastoma without EGFR amplification SLC25A29.a 6395 to 6814 420 to 1       420/420
(100 %)
0 diff
(100 %id)
AW090294 brain, tumor, 5 pooled (see description) SLC25A29.a 6397 to 6814 424 to 7       418/424
(98 %)
0 diff
(100 %id)
AA505726 breast SLC25A29.a 6400 to 6813 414 to 1       414/414
(100 %)
0 diff
(100 %id)
AI025723 parathyroid gland, parathyroid tumor SLC25A29.a 6400 to 6812 435 to 25   AAA   411/411
(100 %)
2 diff
(99.6 %id)
AI128668 heart SLC25A29.a 6400 to 6813 411 to 1       411/411
(100 %)
4 diff
(99.1 %id)
AI400222 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus SLC25A29.a 6400 to 6819 425 to 6   tiling clone,   420/425
(98 %)
0 diff
(100 %id)
AW273456 serous papillary carcinoma, high grade, 2pooled tumors, uterus SLC25A29.a 6400 to 6814 416 to 2       415/416
(99 %)
0 diff
(100 %id)
AW469424 poorly differentiated adenocarcinoma withsignet ring cell features, stomach SLC25A29.a 6400 to 6812 413 to 1       413/413
(100 %)
0 diff
(100 %id)
BE046148 follicular carcinoma, thyroid SLC25A29.a 6401 to 6814 419 to 6       414/419
(98 %)
0 diff
(100 %id)
BE350462 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney SLC25A29.a 6404 to 6812 409 to 1       409/410
(99 %)
1 diff
(99.8 %id)
AW302601 brain, three pooled meningiomas SLC25A29.a 6407 to 6814 412 to 5       408/412
(99 %)
0 diff
(100 %id)
AI299977 carcinoid, lung SLC25A29.a 6409 to 6814 413 to 8       406/413
(98 %)
0 diff
(100 %id)
AI640358 Kidney SLC25A29.a 6413 to 6812 400 to 1       400/400
(100 %)
9 diff
(97.8 %id)
AA284809 ovarian tumor, ovary SLC25A29.a 6414 to 6812 416 to 18   AAA   399/399
(100 %)
3 diff
(99.3 %id)
AA650048   SLC25A29.a 6434 to 6705 270 to 1       270/270
(100 %)
2 diff
(99.3 %id)
AI241794 brain, tumor, 5 pooled (see description) SLC25A29.a 6434 to 6814 386 to 6       381/386
(98 %)
0 diff
(100 %id)
AW470364 carcinoid, lung SLC25A29.a 6434 to 6812 385 to 1       385/385
(100 %)
10 diff
(97.5 %id)
AW090027 brain, tumor, 5 pooled (see description) SLC25A29.a 6449 to 6812 383 to 20   AAA   364/364
(100 %)
4 diff
(99.0 %id)
BI001817 head_normal SLC25A29.a 6451 to 6812 1 to 363       363/389
(93 %)
9 diff
(97.7 %id)
BF589015 Kidney SLC25A29.a 6457 to 6812 356 to 1       356/356
(100 %)
0 diff
(100 %id)
AI934336 Kidney SLC25A29.a 6464 to 6814 353 to 3       351/353
(99 %)
0 diff
(100 %id)
BF477714 Prostate SLC25A29.a 6470 to 6812 362 to 20   AAA   343/343
(100 %)
0 diff
(100 %id)
H15377 whole brain SLC25A29.a 6477 to 6814 354 to 8       347/372
(93 %)
0 diff
(100 %id)
H69512 nose, olfactory epithelium SLC25A29.a 6491 to 6818 330 to 1   fully sequenced,   330/330
(100 %)
5 diff
(98.5 %id)
AI041281   SLC25A29.a 6491 to 6812 336 to 15   AAA   322/322
(100 %)
1 diff
(99.7 %id)
AW118536 brain, tumor, 5 pooled (see description) SLC25A29.a 6491 to 6812 323 to 1       323/323
(100 %)
1 diff
(99.7 %id)
D60021   SLC25A29.a 6499 to 6812 308 to 1   fully sequenced,   308/308
(100 %)
5 diff
(98.4 %id)
BM547356 ovary (pool of 3) SLC25A29.a 6500 to 6812 1 to 313   AAA   313/313
(100 %)
0 diff
(100 %id)
BU729825 eye, Retina Foveal and Macular SLC25A29.a 6501 to 6812 330 to 19   AAA   312/312
(100 %)
2 diff
(99.4 %id)
AA614238   SLC25A29.a 6504 to 6814 327 to 17       311/327
(95 %)
0 diff
(100 %id)
R85918 brain SLC25A29.a 6511 to 6778 270 to 2       269/271
(99 %)
0 diff
(100 %id)
AW571741 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors SLC25A29.a 6511 to 6812 302 to 1       302/302
(100 %)
1 diff
(99.7 %id)
BE670983 carcinoid, lung SLC25A29.a 6511 to 6786 1 to 276     Submitted on the opposite strand 276/276
(100 %)
1 diff
(99.7 %id)
BM671089 eye, optic nerve SLC25A29.a 6514 to 6812 317 to 19   AAA   299/304
(98 %)
2 diff
(99.4 %id)
BU729087 eye, optic nerve SLC25A29.a 6514 to 6812 317 to 19   AAA   299/304
(98 %)
2 diff
(99.4 %id)
AW516692 ovary, papillary serous ovarian metastasis SLC25A29.a 6516 to 6811 295 to 1       295/295
(100 %)
1 diff
(99.7 %id)
AW572232 serous papillary carcinoma, high grade, 2pooled tumors, uterus SLC25A29.a 6517 to 6813 297 to 1       297/297
(100 %)
0 diff
(100 %id)
AW515188 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus SLC25A29.a 6517 to 6814 298 to 2       297/298
(99 %)
0 diff
(100 %id)
BM701941 eye, optic nerve SLC25A29.a 6518 to 6812 1 to 295   AAA   295/295
(100 %)
0 diff
(100 %id)
EC523445 Prostate SLC25A29.a 6534 to 6636 1 to 102       102/102
(100 %)
2 diff
(98.1 %id)
AI798585 Prostate SLC25A29.a 6536 to 6812 304 to 27   AAA   278/278
(100 %)
10 diff
(96.5 %id)
BI963962 Islets of Langerhans, Pancreas SLC25A29.a 6536 to 6810 12 to 286       275/286
(96 %)
6 diff
(98.0 %id)
AI392825 B-cell, chronic lymphotic leukemia SLC25A29.a 6537 to 6812 292 to 17   AAA   276/276
(100 %)
0 diff
(100 %id)
Z40518 brain, total brain SLC25A29.a 6539 to 6812 275 to 1       275/275
(100 %)
2 diff
(99.3 %id)
BI964114 Islets of Langerhans, Pancreas SLC25A29.a 6539 to 6814 15 to 290       276/296
(93 %)
12 diff
(96.0 %id)
DW428687 Liver SLC25A29.a 6548 to 6814 8 to 274       267/275
(97 %)
7 diff
(97.5 %id)
BM509481 insulinoma, Pancreas SLC25A29.a 6549 to 6812 1 to 264   AAA   264/264
(100 %)
3 diff
(98.9 %id)
BM509233 insulinoma, Pancreas SLC25A29.a 6554 to 6812 274 to 16   AAA   259/263
(98 %)
0 diff
(100 %id)
AA469975   SLC25A29.a 6557 to 6814 260 to 3       258/260
(99 %)
0 diff
(100 %id)
AI869580 anaplastic oligodendroglioma, brain SLC25A29.a 6557 to 6812 256 to 1       256/256
(100 %)
0 diff
(100 %id)
AI537819 serous papillary carcinoma, high grade, 2pooled tumors, uterus SLC25A29.a 6566 to 6801 284 to 49   AAA   236/247
(95 %)
0 diff
(100 %id)
AI810684 Prostate SLC25A29.a 6571 to 6812 262 to 21   AAA   242/242
(100 %)
2 diff
(99.2 %id)
BU732438 eye, optic nerve SLC25A29.a 6583 to 6812 248 to 19   fully sequenced, AAA   230/230
(100 %)
0 diff
(100 %id)
AI701744 carcinoid, lung SLC25A29.a 6584 to 6814 231 to 1       231/231
(100 %)
1 diff
(99.6 %id)
AI370410 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors SLC25A29.a 6589 to 6812 258 to 35   AAA   224/224
(100 %)
4 diff
(98.3 %id)
BM671022 eye, optic nerve SLC25A29.a 6589 to 6812 242 to 19   fully sequenced, AAA   224/224
(100 %)
2 diff
(99.2 %id)
AI537827 serous papillary carcinoma, high grade, 2pooled tumors, uterus SLC25A29.a 6602 to 6801 248 to 49   AAA   200/211
(94 %)
0 diff
(100 %id)
AI648647 serous papillary carcinoma, high grade, 2pooled tumors, uterus SLC25A29.a 6604 to 6814 214 to 4       211/214
(98 %)
0 diff
(100 %id)
AW474315 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus SLC25A29.a 6612 to 6812 201 to 1       201/201
(100 %)
2 diff
(99.1 %id)
AI914687 ovary, tumor, 5 pooled (see description) SLC25A29.a 6617 to 6814 199 to 2       198/200
(99 %)
0 diff
(100 %id)
AW571920 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors SLC25A29.a 6624 to 6813 190 to 1       190/190
(100 %)
0 diff
(100 %id)
AL043355 testis SLC25A29.a 6662 to 6814 1 to 153       153/223
(68 %)
2 diff
(99.2 %id)
CF529947 placenta SLC25A29.a 6666 to 6819 172 to 19   AAA   154/154
(100 %)
1 diff
(99.4 %id)
AW516067 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus SLC25A29.a 6669 to 6814 148 to 3       146/148
(98 %)
0 diff
(100 %id)
BX367706   SLC25A29.a 6702 to 6756 80 to 26       864/976
(88 %)
17 diff
(98.3 %id)
AA284657 ovarian tumor, ovary SLC25A29.a 6703 to 6797 1 to 94   fully sequenced,   94/94
(100 %)
1 diff
(99.0 %id)
AA290785 ovarian tumor, ovary SLC25A29.a 6752 to 6812 61 to 1   fully sequenced,   61/61
(100 %)
0 diff
(100 %id)
BM926426 brain SLC25A29.b 1 to 651 8 to 667   tiling clone,   660/1098
(60 %)
27 diff
(97.6 %id)
CR986154 T-Lymphocytes SLC25A29.b 47 to 447 1 to 401   tiling clone,   401/403
(99 %)
2 diff
(99.6 %id)
DA713209   SLC25A29.b 48 to 607 2 to 558   capped   557/557
(100 %)
4 diff
(99.3 %id)
AK096294   SLC25A29.b 50 to 2291 1 to 2240 G291C tiling clone, available from FLJ,   2240/2240
(100 %)
5 diff
(99.8 %id)
DA701459   SLC25A29.b 51 to 543 2 to 492   capped   491/492
(99 %)
3 diff
(99.4 %id)
DA453103 tongue, tumor tissue SLC25A29.c 1 to 551 2 to 552   tiling clone, capped   551/551
(100 %)
1 diff
(99.9 %id)
DA502980 brain SLC25A29.c 2 to 186 2 to 186   capped   185/185
(100 %)
0 diff
(100 %id)
DA882059   SLC25A29.c 2 to 567 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DB253361 uterus SLC25A29.c 2 to 569 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
BX247983 fetal brain SLC25A29.c 10 to 2372 1 to 2363   tiling clone,   2363/2363
(100 %)
0 diff
(100 %id)
BX420544 brain, fetal brain SLC25A29.c 10 to 1049 1 to 1035       1035/1041
(99 %)
27 diff
(97.5 %id)
BX432583 brain, fetal brain SLC25A29.c 10 to 887 1 to 874       874/886
(98 %)
7 diff
(99.3 %id)
BX432584 brain, fetal brain SLC25A29.c 10 to 474 1 to 467       467/514
(90 %)
11 diff
(97.9 %id)
BX449961 brain, fetal brain SLC25A29.c 10 to 952 1 to 942       942/942
(100 %)
10 diff
(99.0 %id)
NM_001039355.1   SLC25A29.c 10 to 2379 1 to 2370   RefSeq,   2370/2370
(100 %)
0 diff
(100 %id)
DR003129 fetal brain SLC25A29.c 11 to 524 8 to 521       514/521
(98 %)
8 diff
(98.5 %id)
BM927262 brain SLC25A29.c 12 to 538 24 to 551       528/1208
(43 %)
13 diff
(99.0 %id)
BX353036 Neuroblastoma Cot 10-normalized SLC25A29.c 16 to 913 1 to 898       898/898
(100 %)
36 diff
(96.0 %id)
BX341203   SLC25A29.c 16 to 340 1 to 324       324/328
(98 %)
5 diff
(98.5 %id)
DA470058   SLC25A29.c 36 to 530 2 to 497   capped   496/496
(100 %)
2 diff
(99.6 %id)
CR600250 Neuroblastoma Cot 25-normalized SLC25A29.c 58 to 2288 1 to 2231       2231/2231
(100 %)
0 diff
(100 %id)
BX332815 Neuroblastoma Cot 25-normalized SLC25A29.c 58 to 1006 1 to 947       947/947
(100 %)
6 diff
(99.4 %id)
BP259163 heart SLC25A29.c 59 to 622 1 to 564       564/564
(100 %)
1 diff
(99.9 %id)
AK172788   SLC25A29.c 64 to 2377 1 to 2314   tiling clone, available from FLJ, AAA   2314/2314
(100 %)
4 diff
(99.9 %id)
BP239707 Liver SLC25A29.c 64 to 674 1 to 611       611/611
(100 %)
9 diff
(98.6 %id)
BI919189 brain SLC25A29.c 65 to 902 24 to 866       843/867
(97 %)
13 diff
(98.6 %id)
TI_57239533   SLC25A29.c 65 to 902 24 to 866       843/867
(97 %)
13 diff
(98.6 %id)
BE884788 leiomyosarcoma, uterus SLC25A29.c 69 to 713 1 to 650       650/926
(70 %)
13 diff
(98.6 %id)
DB473817 hippocampus SLC25A29.c 70 to 805 1 to 734       734/734
(100 %)
7 diff
(99.1 %id)
BU521227 leiomyosarcoma, uterus SLC25A29.c 71 to 896 12 to 845       834/890
(93 %)
24 diff
(97.4 %id)
TI_159677659   SLC25A29.c 71 to 901 46 to 862       817/1043
(78 %)
21 diff
(98.0 %id)
CF131952 Chondrosarcoma Lung Metastasis cell lines, lung SLC25A29.c 72 to 782 1 to 709       709/709
(100 %)
4 diff
(99.5 %id)
CR614751 fetal brain SLC25A29.c 74 to 2373 1 to 2300       2300/2300
(100 %)
0 diff
(100 %id)
BX407823 brain, fetal brain SLC25A29.c 74 to 1011 1 to 937       937/937
(100 %)
11 diff
(98.9 %id)
BX420127 brain, fetal brain SLC25A29.c 74 to 1098 1 to 1004       1004/1004
(100 %)
62 diff
(93.9 %id)
BI831635 brain, medulla SLC25A29.c 80 to 725 1 to 647       647/647
(100 %)
20 diff
(97.0 %id)
TI_57172384   SLC25A29.c 80 to 725 26 to 672       647/672
(96 %)
14 diff
(98.0 %id)
BI549240 brain, hippocampus SLC25A29.c 87 to 290 1 to 203       203/203
(100 %)
5 diff
(97.6 %id)
CR983856 T-Lymphocytes SLC25A29.c 89 to 578 1 to 496       496/496
(100 %)
8 diff
(98.4 %id)
BM762993 myeloma SLC25A29.c 89 to 518 1 to 430       430/430
(100 %)
0 diff
(100 %id)
CB215651 normal endometrium, late proliferativephase, cycle day 13, uterus SLC25A29.c 90 to 743 1 to 655       655/655
(100 %)
2 diff
(99.7 %id)
DA710628   SLC25A29.c 90 to 591 2 to 501   capped   500/500
(100 %)
2 diff
(99.6 %id)
DA877403 Prostate SLC25A29.c 90 to 668 2 to 581   capped   580/580
(100 %)
2 diff
(99.7 %id)
BM146732 leukopheresis SLC25A29.c 90 to 241 1 to 152       152/152
(100 %)
4 diff
(97.4 %id)
DB181755 liver, tumor tissue SLC25A29.c 90 to 434 2 to 346   capped   345/345
(100 %)
2 diff
(99.5 %id)
DB256269 uterus SLC25A29.c 90 to 446 2 to 358   capped   357/357
(100 %)
0 diff
(100 %id)
AK123821   SLC25A29.c 92 to 2377 1 to 2284   available from FLJ,   2284/2284
(100 %)
2 diff
(100.0 %id)
DA391960 thalamus SLC25A29.c 93 to 687 2 to 596   capped   595/595
(100 %)
1 diff
(99.9 %id)
DA623009 Kidney SLC25A29.c 93 to 667 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
DA711481   SLC25A29.c 93 to 663 2 to 570   capped   569/569
(100 %)
2 diff
(99.7 %id)
DA678436   SLC25A29.c 94 to 629 2 to 538   capped   537/537
(100 %)
5 diff
(99.1 %id)
T08085   SLC25A29.c 99 to 260 1 to 162       162/162
(100 %)
0 diff
(100 %id)
CR592557 Neuroblastoma Cot 25-normalized SLC25A29.c 103 to 2360 1 to 2258       2258/2258
(100 %)
0 diff
(100 %id)
BX376193 Neuroblastoma Cot 25-normalized SLC25A29.c 103 to 1164 1 to 1056       1056/1078
(97 %)
20 diff
(98.2 %id)
BI907438 leukocyte SLC25A29.c 117 to 784 1 to 666       666/666
(100 %)
4 diff
(99.4 %id)
TI_57232419   SLC25A29.c 117 to 784 29 to 694       666/694
(95 %)
6 diff
(99.2 %id)
BE791151 lung, small cell carcinoma SLC25A29.c 123 to 948 1 to 823       823/1078
(76 %)
19 diff
(98.3 %id)
CN403955 embryonic stem cells, cell lines H1, H7, andH9 SLC25A29.c 152 to 456 1 to 305       305/305
(100 %)
1 diff
(99.7 %id)
DA717883   SLC25A29.c 239 to 666 162 to 593   capped   562/592
(94 %)
24 diff
(96.0 %id)
BU174988 epidermoid carcinoma, cell line, salivary gland SLC25A29.c 334 to 1182 34 to 892       859/958
(89 %)
26 diff
(97.3 %id)
BQ673497 epidermoid carcinoma, cell line, salivary gland SLC25A29.c 334 to 980 9 to 665       657/1026
(64 %)
31 diff
(97.0 %id)
TI_57200925   SLC25A29.c 373 to 1052 76 to 758       686/761
(90 %)
7 diff
(99.1 %id)
BX283622 adenocarcinoma, cell line, breast SLC25A29.c 379 to 875 5 to 501       501/501
(100 %)
2 diff
(99.7 %id)
BI824048 pooled brain, lung, testis SLC25A29.c 379 to 1052 1 to 674       674/677
(99 %)
4 diff
(99.5 %id)
BQ279121 adenocarcinoma, cell line, breast SLC25A29.c 379 to 1239 2 to 870       869/1003
(86 %)
18 diff
(98.3 %id)
BU856747 adenocarcinoma, cell line, breast SLC25A29.c 379 to 1124 2 to 750       749/961
(77 %)
7 diff
(99.3 %id)
BU957245 adenocarcinoma, cell line, breast SLC25A29.c 379 to 1114 2 to 744       743/954
(77 %)
20 diff
(98.0 %id)
TI_1752769734   SLC25A29.c 385 to 1473 47 to 1132       1086/1259
(86 %)
11 diff
(99.2 %id)
BC132964 Brain, cerebellum, PCR rescued clones SLC25A29.c 388 to 2216 1 to 1829       1829/1829
(100 %)
1 diff
(100.0 %id)
BC132966 Brain, cerebellum, PCR rescued clones SLC25A29.c 388 to 2216 1 to 1829       1829/1829
(100 %)
1 diff
(100.0 %id)
DA924407 small intestine SLC25A29.c 388 to 963 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
AV747722 Pituitary SLC25A29.c 407 to 736 1 to 331       331/331
(100 %)
8 diff
(97.6 %id)
BE266647 lung, small cell carcinoma SLC25A29.c 427 to 1162 1 to 729       729/743
(98 %)
25 diff
(96.7 %id)
DA157091 amygdala SLC25A29.c 428 to 992 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
CN341062 embryonic stem cells, cell lines H1, H7, andH9 SLC25A29.c 441 to 1081 3 to 642       640/642
(99 %)
6 diff
(99.1 %id)
DB324194   SLC25A29.c 1820 to 2377 558 to 1       558/558
(100 %)
0 diff
(100 %id)
CN403954 embryonic stem cells, cell lines H1, H7, andH9 SLC25A29.d 1 to 421 12 to 432   tiling clone,   421/432
(97 %)
6 diff
(98.7 %id)
DB727823 hippocampus SLC25A29.d 53 to 729 1 to 677   tiling clone,   677/677
(100 %)
8 diff
(98.9 %id)
DB475680 hippocampus SLC25A29.d 53 to 786 1 to 733   tiling clone,   733/733
(100 %)
10 diff
(98.7 %id)
DA589489 lung SLC25A29.d 80 to 418 2 to 342   capped   341/341
(100 %)
5 diff
(98.6 %id)
BX367707   SLC25A29.e 1 to 934 1 to 933 H7T E8R R10G G11A A12R ... tiling clone,   933/933
(100 %)
9 diff
(99.1 %id)
AK310069 Spleen SLC25A29.e 74 to 699 1 to 626   tiling clone,   626/626
(100 %)
2 diff
(99.7 %id)
CB958369 Pooled-Glandular SLC25A29.e 75 to 710 1 to 641   AAA   641/811
(79 %)
24 diff
(97.1 %id)
DA936372 Spleen SLC25A29.e 75 to 668 2 to 596   capped   595/595
(100 %)
3 diff
(99.5 %id)
BI828620 brain, medulla SLC25A29.e 85 to 904 1 to 819       819/823
(99 %)
4 diff
(99.6 %id)
TI_57175320   SLC25A29.e 85 to 904 29 to 847       819/851
(96 %)
10 diff
(98.9 %id)
BI838929 pooled pancreas and spleen SLC25A29.e 278 to 801 251 to 785       745/785
(94 %)
29 diff
(96.4 %id)
TI_57167002   SLC25A29.e 278 to 801 251 to 785       745/785
(94 %)
29 diff
(96.4 %id)
BX368247   SLC25A29.e 330 to 589 1 to 260       260/265
(98 %)
1 diff
(99.7 %id)
CN341071 embryonic stem cells, cell lines H1, H7, andH9 SLC25A29.e 462 to 1067 1 to 606   tiling clone,   606/606
(100 %)
0 diff
(100 %id)
AK289627 amygdala SLC25A29.e 623 to 2162 1 to 1540   tiling clone,   1540/1540
(100 %)
3 diff
(99.9 %id)
DA157490 amygdala SLC25A29.e 624 to 1116 2 to 495   capped   494/494
(100 %)
4 diff
(99.2 %id)
DA167252 amygdala SLC25A29.e 624 to 1159 2 to 537   capped   536/536
(100 %)
2 diff
(99.7 %id)
TI_44167368   SLC25A29.f 1 to 710 61 to 766 Q2A R3G L67S A68P D70T ... tiling clone,   706/768
(91 %)
14 diff
(98.2 %id)
DA157517 amygdala SLC25A29.g 1 to 533 2 to 538   tiling clone, capped   537/537
(100 %)
4 diff
(99.3 %id)
BF849949 lung_normal SLC25A29.g 462 to 771 407 to 99   tiling clone, Submitted on the opposite strand 309/407
(75 %)
0 diff
(100 %id)
CN285997 embryonic stem cells, cell lines H1, H7, andH9 SLC25A29.g 683 to 941 1 to 259   tiling clone,   259/259
(100 %)
3 diff
(98.9 %id)
BI033011 nervous_normal SLC25A29.g 883 to 1205 17 to 339   tiling clone,   323/339
(95 %)
7 diff
(98.0 %id)
BI033012 nervous_normal SLC25A29.g 884 to 1205 38 to 360   tiling clone,   323/360
(89 %)
6 diff
(98.4 %id)
BG774966 carcinoma, cell line, Prostate SLC25A29.h 1 to 870 1 to 871 G5E A6Q V7L V8S L9* tiling clone,   871/950
(91 %)
62 diff
(93.5 %id)
BU542403 carcinoma, cell line, Prostate SLC25A29.h 3 to 878 1 to 881   tiling clone,   881/886
(99 %)
9 diff
(99.0 %id)
BG775422 carcinoma, cell line, Prostate SLC25A29.h 1129 to 2031 905 to 2   tiling clone,   904/906
(99 %)
0 diff
(100 %id)
DB460692 testis SLC25A29.i-u 1 to 389 1 to 389   tiling clone,   389/389
(100 %)
1 diff
(99.8 %id)
BM147072 leukopheresis SLC25A29.i-u 26 to 536 1 to 512       512/512
(100 %)
4 diff
(99.3 %id)
BE207149 lung, small cell carcinoma SLC25A29.i-u 333 to 568 1 to 236   tiling clone,   236/236
(100 %)
0 diff
(100 %id)
CN293975 embryonic stem cells, DMSO-treated H9 cellline SLC25A29.i-u 422 to 657 1 to 236   tiling clone,   236/236
(100 %)
0 diff
(100 %id)
DA201175 brain SLC25A29.j 1 to 577 2 to 578   tiling clone, capped   577/577
(100 %)
1 diff
(99.9 %id)
BX388360 Neuroblastoma Cot 25-normalized SLC25A29.j 32 to 1011 1 to 977 L5S T6P L7W E8R S9A ... tiling clone,   977/977
(100 %)
8 diff
(99.2 %id)
CN403956 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 SLC25A29.j 92 to 482 1 to 392       392/392
(100 %)
1 diff
(99.8 %id)
BX326200 Neuroblastoma Cot 25-normalized SLC25A29.j 178 to 1092 1 to 913 G137X tiling clone,   913/945
(96 %)
38 diff
(96.0 %id)
BF740920 bocio_tumor SLC25A29.k 1 to 371 1 to 369 R9E N10I S11V V12C C13A ... tiling clone,   369/381
(96 %)
5 diff
(98.7 %id)
DA394412 thalamus SLC25A29.l 1 to 516 2 to 517   tiling clone, capped   516/516
(100 %)
27 diff
(94.8 %id)
DA243533 brain SLC25A29.l 169 to 747 2 to 580   tiling clone, capped   579/579
(100 %)
9 diff
(98.5 %id)
BF740829 bocio_tumor SLC25A29.l 434 to 785 355 to 4   tiling clone, Submitted on the opposite strand 352/355
(99 %)
0 diff
(100 %id)
CN370419 embryonic stem cells, cell lines H1, H7, andH9 SLC25A29.l 544 to 1160 5 to 623   tiling clone,   619/623
(99 %)
6 diff
(99.1 %id)
CV428087 head_neck SLC25A29.l 581 to 931 365 to 15     Submitted on the opposite strand 351/468
(75 %)
0 diff
(100 %id)
CN370421 embryonic stem cells, cell lines H1, H7, andH9 SLC25A29.l 643 to 849 1 to 207       207/207
(100 %)
0 diff
(100 %id)
CN370420 embryonic stem cells, cell lines H1, H7, andH9 SLC25A29.l 820 to 1395 1 to 575       575/575
(100 %)
2 diff
(99.7 %id)
CN370418 embryonic stem cells, cell lines H1, H7, andH9 SLC25A29.l 1019 to 1774 1 to 757 exact tiling clone,   757/757
(100 %)
3 diff
(99.7 %id)
BE062527 breast SLC25A29.l 1076 to 1355 12 to 294       283/295
(95 %)
15 diff
(95.0 %id)
DA443026 tongue, tumor tissue SLC25A29.m 1 to 568 2 to 570 W55V P56A L57A F58L L60T ... tiling clone, capped   569/569
(100 %)
2 diff
(99.7 %id)
DA556898   SLC25A29.n 1 to 559 2 to 560   tiling clone, capped   559/559
(100 %)
2 diff
(99.7 %id)
DB154566 thymus SLC25A29.o 1 to 549 2 to 550   tiling clone, capped   549/549
(100 %)
0 diff
(100 %id)
DB262583 uterus SLC25A29.o 488 to 1056 2 to 570 exact tiling clone, capped   569/569
(100 %)
0 diff
(100 %id)
BX441315 brain, fetal brain SLC25A29.o 632 to 1531 1 to 902       902/902
(100 %)
15 diff
(98.4 %id)
BX449924 brain, fetal brain SLC25A29.o 632 to 1546 1 to 916       916/916
(100 %)
19 diff
(98.0 %id)
CA454649   SLC25A29.o 632 to 1443 11 to 827       817/869
(94 %)
13 diff
(98.6 %id)
BF685430 leiomyosarcoma cell line, uterus SLC25A29.o 645 to 1362 1 to 716       716/793
(90 %)
21 diff
(97.4 %id)
BG169747 hypernephroma, cell line, Kidney SLC25A29.o 656 to 1010 1 to 363       363/474
(76 %)
12 diff
(97.5 %id)
CN341057 embryonic stem cells, cell lines H1, H7, andH9 SLC25A29.o 677 to 1291 1 to 617       617/617
(100 %)
4 diff
(99.4 %id)
CN341070 embryonic stem cells, cell lines H1, H7, andH9 SLC25A29.o 702 to 1439 1 to 738       738/738
(100 %)
0 diff
(100 %id)
CN341063 embryonic stem cells, cell lines H1, H7, andH9 SLC25A29.o 724 to 1267 1 to 544       544/544
(100 %)
2 diff
(99.7 %id)
BM725043 eye, fetal eye SLC25A29.o 732 to 1397 1 to 666       666/666
(100 %)
1 diff
(99.9 %id)
BP340073 Spleen SLC25A29.o 746 to 1325 1 to 580       580/580
(100 %)
1 diff
(99.9 %id)
CN341067 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 SLC25A29.o 766 to 1100 1 to 335       335/335
(100 %)
0 diff
(100 %id)
BE793118 lung, small cell carcinoma SLC25A29.o 769 to 1547 1 to 762       762/1019
(74 %)
12 diff
(98.9 %id)
CV409685 head_neck SLC25A29.o 772 to 1098 336 to 1     Submitted on the opposite strand 336/336
(100 %)
21 diff
(93.8 %id)
CR606012 T cells (Jurkat cell line) Cot10-normalized SLC25A29.o 774 to 2148 1 to 1375   tiling clone,   1375/1375
(100 %)
0 diff
(100 %id)
BX341257   SLC25A29.o 774 to 1650 1 to 875       875/875
(100 %)
16 diff
(98.2 %id)
BX346781   SLC25A29.o 774 to 1061 1 to 289       289/289
(100 %)
4 diff
(98.7 %id)
BX326203 Neuroblastoma Cot 10-normalized SLC25A29.o 779 to 1722 1 to 948       948/957
(99 %)
38 diff
(96.1 %id)
BX367730 Neuroblastoma Cot 10-normalized SLC25A29.o 783 to 1413 1 to 630       630/723
(87 %)
8 diff
(98.9 %id)
BX408238 brain, fetal brain SLC25A29.o 812 to 1689 1 to 877       877/879
(99 %)
6 diff
(99.4 %id)
CK429510 eye, lacrimal gland SLC25A29.o 829 to 1048 1 to 220       220/220
(100 %)
4 diff
(98.2 %id)
BX325829 Neuroblastoma Cot 25-normalized SLC25A29.o 835 to 1689 1 to 855       855/858
(99 %)
16 diff
(98.2 %id)
BM805176 ovary (pool of 3) SLC25A29.o 898 to 1575 106 to 789       684/1259
(54 %)
28 diff
(97.8 %id)
BX346819 Neuroblastoma Cot 25-normalized SLC25A29.o 903 to 1721 7 to 820       814/879
(92 %)
23 diff
(97.4 %id)
TI_57171479   SLC25A29.o 904 to 1627 34 to 771   AAA   738/836
(88 %)
30 diff
(96.5 %id)
BI827584 brain, medulla SLC25A29.o 908 to 1113 1 to 208       208/209
(99 %)
4 diff
(98.1 %id)
BQ887476 carcinoma, cell line, Prostate SLC25A29.o 911 to 1759 15 to 886       872/948
(91 %)
55 diff
(94.2 %id)
BX408811 brain, fetal brain SLC25A29.o 912 to 1686 1 to 779       779/917
(84 %)
26 diff
(97.2 %id)
BU169124 ductal carcinoma, cell line, Pancreas SLC25A29.o 914 to 1443 74 to 604       531/1382
(38 %)
6 diff
(99.6 %id)
BQ957694 carcinoma, cell line, Prostate SLC25A29.o 918 to 1736 1 to 829       829/1002
(82 %)
19 diff
(98.2 %id)
BU542148 carcinoma, cell line, Prostate SLC25A29.o 918 to 1749 1 to 845       845/855
(98 %)
18 diff
(97.9 %id)
BQ278740 adenocarcinoma, cell line, breast SLC25A29.o 951 to 1444 1 to 498       498/1347
(36 %)
23 diff
(98.3 %id)
BU538079 adenocarcinoma, cell line, breast SLC25A29.o 951 to 1646 1 to 703       703/994
(70 %)
22 diff
(97.8 %id)
BU538793 adenocarcinoma, cell line, breast SLC25A29.o 951 to 1828 1 to 881       881/896
(98 %)
15 diff
(98.4 %id)
BU860550 adenocarcinoma, cell line, breast SLC25A29.o 951 to 1335 1 to 386       386/1053
(36 %)
12 diff
(98.9 %id)
BX408843 brain, fetal brain SLC25A29.o 961 to 1830 1 to 860       860/860
(100 %)
20 diff
(97.7 %id)
BX388795 Placenta Cot 25-normalized SLC25A29.o 972 to 1838 864 to 1       864/864
(100 %)
19 diff
(97.9 %id)
BX433065 brain, fetal brain SLC25A29.o 979 to 1743 761 to 1       761/904
(84 %)
8 diff
(99.2 %id)
BX368004 Neuroblastoma Cot 25-normalized SLC25A29.o 989 to 1838 847 to 1       847/847
(100 %)
4 diff
(99.6 %id)
BQ942222 sciatic nerve SLC25A29.o 1067 to 1769 12 to 717       706/941
(75 %)
16 diff
(98.3 %id)
CX751959 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass SLC25A29.o 1076 to 1774 1 to 698     Submitted on the opposite strand 698/745
(93 %)
3 diff
(99.6 %id)
CN341072 embryonic stem cells, cell lines H1, H7, andH9 SLC25A29.o 1112 to 1495 1 to 384       384/384
(100 %)
5 diff
(98.7 %id)
BX326075 Neuroblastoma Cot 25-normalized SLC25A29.o 1115 to 1885 760 to 1       760/849
(89 %)
0 diff
(100 %id)
CN341064 embryonic stem cells, cell lines H1, H7, andH9 SLC25A29.o 1143 to 1451 9 to 317       309/317
(97 %)
6 diff
(98.2 %id)
BX408224 brain, fetal brain SLC25A29.o 1144 to 1818 1 to 673       673/687
(97 %)
6 diff
(99.2 %id)
BU196667 melanotic melanoma, cell line, skin SLC25A29.o 1225 to 1833 12 to 625       614/1225
(50 %)
24 diff
(98.1 %id)
BU195970 melanotic melanoma, cell line, skin SLC25A29.o 1227 to 1835 1 to 609       609/957
(63 %)
5 diff
(99.5 %id)
BX450686 brain, fetal brain SLC25A29.o 1231 to 1828 1 to 599       599/601
(99 %)
7 diff
(98.9 %id)
BE383083 brain, neuroblastoma SLC25A29.o 1244 to 1916 1 to 667       667/668
(99 %)
17 diff
(97.5 %id)
BX326381   SLC25A29.o 1299 to 2237 1 to 929       929/930
(99 %)
53 diff
(94.4 %id)
BX449946 brain, fetal brain SLC25A29.o 1377 to 2304 1 to 925       925/925
(100 %)
14 diff
(98.5 %id)
BX460429 brain, fetal brain SLC25A29.o 1377 to 2204 1 to 827       827/827
(100 %)
1 diff
(99.9 %id)
CN341059 embryonic stem cells, cell lines H1, H7, andH9 SLC25A29.o 1385 to 1810 1 to 426       426/426
(100 %)
0 diff
(100 %id)
BF477323 breast, lobullar carcinoma in situ SLC25A29.o 1426 to 1691 313 to 48       266/322
(82 %)
0 diff
(100 %id)
BF001099 breast, lobullar carcinoma in situ SLC25A29.o 1426 to 1691 22 to 287     Submitted on the opposite strand 266/303
(87 %)
3 diff
(99.1 %id)
BE709837 head_neck SLC25A29.o 1436 to 1913 1 to 478       478/478
(100 %)
7 diff
(98.6 %id)
CD106831 brain, Pituitary SLC25A29.o 1441 to 2014 19 to 606       588/1156
(50 %)
19 diff
(98.4 %id)
BE709700 head_neck SLC25A29.o 1442 to 1863 22 to 443       422/450
(93 %)
5 diff
(98.9 %id)
BE709806 head_neck SLC25A29.o 1442 to 1945 8 to 510       503/510
(98 %)
6 diff
(98.9 %id)
BE710050 head_neck SLC25A29.o 1442 to 1884 8 to 450       443/450
(98 %)
6 diff
(98.7 %id)
BF588657 breast, lobullar carcinoma in situ SLC25A29.o 1442 to 1536 1 to 95     Submitted on the opposite strand 95/95
(100 %)
1 diff
(99.0 %id)
TI_151771067   SLC25A29.o 1454 to 1827 106 to 479       374/378
(98 %)
1 diff
(99.8 %id)
TI_59391816   SLC25A29.o 1457 to 2324 51 to 918       868/870
(99 %)
13 diff
(98.6 %id)
BM013874 breast, mammary adenocarcinoma, cell line SLC25A29.o 1458 to 2324 1 to 867       867/869
(99 %)
13 diff
(98.6 %id)
BX369475   SLC25A29.o 1478 to 2087 1 to 614       614/678
(90 %)
37 diff
(94.6 %id)
BE710049 head_neck SLC25A29.o 1512 to 2046 540 to 6       535/540
(99 %)
0 diff
(100 %id)
BF343842 brain, glioblastoma with EGFR amplification SLC25A29.o 1516 to 2283 24 to 784       761/1100
(69 %)
18 diff
(98.4 %id)
BE709783 head_neck SLC25A29.o 1523 to 2046 538 to 13       526/538
(97 %)
0 diff
(100 %id)
BM719804 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid SLC25A29.o 1537 to 2073 1 to 537       537/537
(100 %)
0 diff
(100 %id)
BE002481 breast_normal SLC25A29.o 1563 to 1855 12 to 303       292/316
(92 %)
22 diff
(93.1 %id)
BE710018 head_neck SLC25A29.o 1564 to 2050 490 to 5       486/490
(99 %)
0 diff
(100 %id)
BE002532 breast_normal SLC25A29.o 1574 to 1855 1 to 280       280/289
(96 %)
6 diff
(98.0 %id)
CN341058 embryonic stem cells, cell lines H1, H7, andH9 SLC25A29.o 1579 to 1813 1 to 233       233/233
(100 %)
2 diff
(99.2 %id)
CA393550 eye, RPE/choroid SLC25A29.o 1590 to 2110 1 to 521       521/521
(100 %)
0 diff
(100 %id)
AA456765 ovarian tumor, ovary SLC25A29.o 1616 to 2073 11 to 470       460/470
(97 %)
6 diff
(98.8 %id)
BX326390 Neuroblastoma Cot 10-normalized SLC25A29.o 1788 to 2108 321 to 1       321/321
(100 %)
9 diff
(97.2 %id)
BX326389 Neuroblastoma Cot 10-normalized SLC25A29.o 1794 to 2090 295 to 1       295/295
(100 %)
4 diff
(98.7 %id)
BF858303 prostate_tumor SLC25A29.o 1820 to 2036 217 to 1     Submitted on the opposite strand 217/217
(100 %)
3 diff
(98.7 %id)
CN341055 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 SLC25A29.o 1838 to 2296 1 to 459   tiling clone,   459/459
(100 %)
6 diff
(98.7 %id)
EC459866 Prostate SLC25A29.o 1918 to 2012 13 to 107       95/107
(88 %)
6 diff
(94.4 %id)
AJ713386 bone marrow SLC25A29.o 1977 to 2298 1 to 322       322/322
(100 %)
2 diff
(99.4 %id)
EC584349 Prostate SLC25A29.o 1984 to 2084 98 to 1       98/98
(100 %)
6 diff
(93.9 %id)
BF842697 head_neck SLC25A29.o 2208 to 2413 17 to 221   tiling clone,   205/221
(92 %)
6 diff
(97.3 %id)
BE175104 head_neck SLC25A29.o 2218 to 2402 13 to 197       185/207
(89 %)
7 diff
(96.7 %id)
BM040736 Kidney, Wilms' tumor, cell line SLC25A29.p-u 1 to 809 1 to 799   tiling clone,   799/801
(99 %)
32 diff
(96.1 %id)
CN360154 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells SLC25A29.p-u 317 to 886 1 to 570   tiling clone,   570/570
(100 %)
2 diff
(99.7 %id)
CN360155 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells SLC25A29.p-u 407 to 1152 10 to 757   tiling clone,   748/757
(98 %)
6 diff
(99.3 %id)
BM144246 leukopheresis SLC25A29.p-u 836 to 1310 475 to 1   tiling clone,   475/475
(100 %)
1 diff
(99.8 %id)
BM148432 leukopheresis SLC25A29.p-u 907 to 1310 404 to 1       404/404
(100 %)
4 diff
(99.1 %id)
AI302007 carcinoid, lung SLC25A29.p-u 1055 to 1395 1 to 344     Submitted on the opposite strand 344/344
(100 %)
10 diff
(97.1 %id)
BX347522 Placenta Cot 25-normalized SLC25A29.p-u 1099 to 1689 593 to 1   tiling clone,   593/675
(87 %)
35 diff
(94.9 %id)
BX365134 Placenta Cot 25-normalized SLC25A29.p-u 1194 to 2205 996 to 1 A39S T40D S41L H42P R43Q ... tiling clone,   996/1079
(92 %)
37 diff
(96.6 %id)
BM041490 Kidney, Wilms' tumor, cell line SLC25A29.p-u 1212 to 1767 603 to 24       580/796
(72 %)
0 diff
(100 %id)
BX380479 Placenta Cot 25-normalized SLC25A29.p-u 1230 to 2188 954 to 1 T29D F30I K32E S33I T34H ... tiling clone,   954/970
(98 %)
53 diff
(94.6 %id)
BX347523 Placenta Cot 25-normalized SLC25A29.p-u 1380 to 1695 317 to 1       317/344
(92 %)
6 diff
(98.3 %id)
DB526091 testis SLC25A29.p-u 1399 to 1828 1 to 430     Submitted on the opposite strand 430/430
(100 %)
1 diff
(99.8 %id)
AW088586 ovary, tumor, 5 pooled (see description) SLC25A29.p-u 1408 to 1830 424 to 1       424/424
(100 %)
2 diff
(99.6 %id)
AA610175 thyroid SLC25A29.p-u 1439 to 1839 401 to 1   tiling clone,   401/401
(100 %)
2 diff
(99.6 %id)
BX111136   SLC25A29.p-u 1452 to 1823 1 to 372   AAA Possibly primed on the genome, locally A rich (18/21 A in genome downstream of last aligned base) 372/372
(100 %)
1 diff
(99.8 %id)
AI187404   SLC25A29.p-u 1485 to 1826 344 to 3       342/344
(99 %)
0 diff
(100 %id)
T82289   SLC25A29.p-u 1606 to 1839 234 to 1       234/234
(100 %)
1 diff
(99.6 %id)
GD160356   SLC25A29.p-u 1686 to 1828 8 to 151   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 144/151
(95 %)
6 diff
(96.1 %id)
DB532604 hippocampus SLC25A29.p-u 1821 to 2240 1 to 419   tiling clone, Submitted on the opposite strand 419/420
(99 %)
14 diff
(96.7 %id)
BG959061 colon SLC25A29.p-u 1905 to 2155 1 to 257   tiling clone,   257/259
(99 %)
18 diff
(93.1 %id)
CN341065 embryonic stem cells, DMSO-treated H9 cellline SLC25A29.q 1 to 683 1 to 684 exact tiling clone,   684/684
(100 %)
6 diff
(99.2 %id)
DA566265 heart SLC25A29.r 1 to 562 2 to 563 exact tiling clone, capped   562/562
(100 %)
1 diff
(99.9 %id)
BF847789 lung_normal SLC25A29.r 407 to 523 1 to 118       118/139
(84 %)
7 diff
(95.0 %id)
BF351370 head_neck Gene SLC25A29, variant not shown         Suspected internal deletion, this clone was ignored    
BX325958 Placenta Cot 25-normalized Gene SLC25A29, variant not shown         This clone was ignored    
BX380480 Placenta Cot 25-normalized Gene SLC25A29, variant not shown         This clone was ignored    
AK022257 mammary gland Gene SLC25A29, variant not shown       available from FLJ, This clone was ignored    
DN999467   Gene SLC25A29, variant not shown         Suspected internal deletion, this clone was ignored    
AU147498 mammary gland Gene SLC25A29, variant not shown         This clone was ignored    
AU121739 mammary gland Gene SLC25A29, variant not shown       capped This clone was ignored    
DW411463 Liver Gene SLC25A29, variant not shown         Suspected internal deletion, this clone was ignored    
DA328919 hippocampus Gene SLC25A29, variant not shown       capped Suspected internal deletion, this clone was ignored    
DA328937 hippocampus Gene SLC25A29, variant not shown       capped Suspected internal deletion, this clone was ignored    
R33710 placenta Gene SLC25A29, variant not shown         Suspected internal deletion, this clone was ignored    
AA021099 eye, retina Gene SLC25A29, variant not shown         Suspected internal deletion, this clone was ignored    
AA021587 eye, retina Gene SLC25A29, variant not shown         Suspected internal deletion, this clone was ignored    
AI245657 Kidney Gene SLC25A29, variant not shown         Suspected internal deletion, this clone was ignored    
AI953156 pooled germ cell tumors Gene SLC25A29, variant not shown         This clone was ignored    
AI968865 pooled germ cell tumors Gene SLC25A29, variant not shown         This clone was ignored    
AI990047 pooled germ cell tumors Gene SLC25A29, variant not shown         This clone was ignored    
AI968781 pooled germ cell tumors Gene SLC25A29, variant not shown         This clone was ignored    
AW025924 pooled germ cell tumors Gene SLC25A29, variant not shown         This clone was ignored    
AW205769   Gene SLC25A29, variant not shown       AAA This clone was ignored    
AW245258 lung, small cell carcinoma Gene SLC25A29, variant not shown         This clone was ignored    
AW247592 lung, small cell carcinoma Gene SLC25A29, variant not shown         This clone was ignored    
AW248872 lung, small cell carcinoma Gene SLC25A29, variant not shown       AAA Suspected internal deletion, this clone was ignored    
AW249292 lung, small cell carcinoma Gene SLC25A29, variant not shown         Suspected internal deletion, this clone was ignored    
AW589850 pooled germ cell tumors Gene SLC25A29, variant not shown         This clone was ignored    
AW594603 pooled germ cell tumors Gene SLC25A29, variant not shown         Suspected internal deletion, this clone was ignored    
AW615318 2 pooled high-grade transitional celltumors, genitourinary tract Gene SLC25A29, variant not shown         This clone was ignored    
AW629905 2 pooled high-grade transitional celltumors, genitourinary tract Gene SLC25A29, variant not shown         This clone was ignored    
AW771648 Kidney Gene SLC25A29, variant not shown         Suspected internal deletion, this clone was ignored    
BE502186 pooled germ cell tumors Gene SLC25A29, variant not shown         This clone was ignored    
BM511464 insulinoma, Pancreas Gene SLC25A29, variant not shown       AAA Suspected internal deletion, this clone was ignored    
CK823864 insulinoma, Pancreas Gene SLC25A29, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BC142945 Clones donated by RIKEN Gene SLC25A29, variant not shown       AAA This clone was ignored    
DA949080 Spleen Gene SLC25A29, variant not shown       capped This clone was ignored    
DB068106 testis Gene SLC25A29, variant not shown       capped This clone was ignored    
DB339912 testis Gene SLC25A29, variant not shown         This clone was ignored    
DB217683 trachea Gene SLC25A29, variant not shown       capped Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i-u, .j, .k, .l, .m, .n, .o, .p-u, .q, .r Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C